1 withdrawn. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
Follow C2N Diagnostics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease PrecivityAD2 - Early Testing, PrecivityAD2 - Delayed Testing - Alzheimers Disease | Not applicable | Withdrawn | C2N Diagnostics | 2025-07-01 | 2025-12-16 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dementia (1)